BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv7.34.0//EN
X-ORIGINAL-URL:https://oligotherapeutics.org/
X-WR-CALNAME:Oligonucleotide Therapeutics Society
X-WR-CALDESC:Oligonucleotide Therapeutics Society
X-WR-TIMEZONE:UTC
BEGIN:VTIMEZONE
TZID:UTC
X-LIC-LOCATION:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20260626T180612
END:STANDARD
END:VTIMEZONE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-ef1efc5f3850889eb8f957df69564c1b@oligotherapeutics.org
DTSTART;TZID=UTC:20220310T110000
DTEND;TZID=UTC:20220310T120000
DTSTAMP:20220301T133752Z
CREATED:20220301
LAST-MODIFIED:20220426
PRIORITY:5
SEQUENCE:0
TRANSP:OPAQUE
SUMMARY:Antisense Oligonucleotide-based Therapies for Inherited Retinal Diseases: From Mutation to Clinical Trial
DESCRIPTION:
URL:http://oligotherapeutics.org/antisense-oligonucleotide-based-therapies-for-inherited-retinal-diseases-from-mutation-to-clinical-trial/
CATEGORIES:Society Events
ATTACH;FMTTYPE=image/webp:https://oligotherapeutics.org/wp-content/uploads/2021/06/OTS_Upcoming_Webinar.webp
END:VEVENT
END:VCALENDAR